Nova Eye Medical Limited

ASX:EYE Rapport sur les actions

Capitalisation boursière : AU$55.0m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Nova Eye Medical Gestion

Gestion contrôle des critères 4/4

We currently do not have sufficient information about the CEO.

Informations clés

Tom Spurling

Directeur général

AU$252.6k

Rémunération totale

Pourcentage du salaire du PDG83.5%
Durée du mandat du directeur général4yrs
Propriété du PDG0.4%
Durée moyenne d'occupation des postes de direction6.1yrs
Durée moyenne du mandat des membres du conseil d'administration6.1yrs

Mises à jour récentes de la gestion

Recent updates

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Analyse de la rémunération des PDG

Comment la rémunération de Tom Spurling a-t-elle évolué par rapport aux bénéfices de Nova Eye Medical?
DateRémunération totaleSalaireBénéfices de l'entreprise
Dec 31 2023n/an/a

-AU$14m

Sep 30 2023n/an/a

-AU$15m

Jun 30 2023AU$253kAU$211k

-AU$15m

Mar 31 2023n/an/a

-AU$13m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$9m

Jun 30 2022AU$311kAU$191k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$6m

Sep 30 2021n/an/a

-AU$5m

Jun 30 2021AU$72kAU$66k

-AU$4m

Dec 31 2020n/an/a

-AU$9m

Sep 30 2020n/an/a

-AU$10m

Jun 30 2020n/an/a

-AU$10m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$328kAU$306k

-AU$7m

Mar 31 2019n/an/a

-AU$7m

Dec 31 2018n/an/a

-AU$6m

Sep 30 2018n/an/a

-AU$6m

Jun 30 2018AU$329kAU$300k

-AU$5m

Rémunération vs marché: Tom's total compensation ($USD169.66K) is below average for companies of similar size in the Australian market ($USD299.11K).

Rémunération et revenus: Tom's compensation has been consistent with company performance over the past year.


PDG

Tom Spurling (62 yo)

4yrs

Titularisation

AU$252,551

Compensation

Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is an Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling wa...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Victor Previn
Founder & Executive Chairman23.1yrsAU$236.84kpas de données
Thomas Spurling
MD & Executive Directorno dataAU$252.55k0.37%
A$ 202.9k
Liam Cook
Chief Financial Officerno datapas de donnéespas de données
Keith Byrne
Vice President of Global Operationsno datapas de donnéespas de données
Mark Flynn
Investor Relationsno datapas de donnéespas de données
Kate Hunt
Head of Marketingno datapas de donnéespas de données
David Lubeck
Chief Medical Officer5.8yrspas de donnéespas de données
Joaquin Wolff
President of Ellex iTrack6.1yrspas de donnéespas de données
Kimberley Menzies
Group Financial Controller & Global Finance Manager8.8yrspas de donnéespas de données
Simon Jeremy Gray
Company Secretary4.2yrspas de donnéespas de données
Don Watton
Vice President of Global Serviceno dataAU$143.97kpas de données
Meera Verma
Advisor to the Boardno dataAU$243.97kpas de données

6.1yrs

Durée moyenne de l'emploi

66yo

Âge moyen

Gestion expérimentée: EYE's management team is seasoned and experienced (6.1 years average tenure).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Victor Previn
Founder & Executive Chairman23.1yrsAU$236.84kpas de données
Thomas Spurling
MD & Executive Director4yrsAU$252.55k0.37%
A$ 202.9k
Rahmon Coupe
Independent Director11.3yrsAU$55.16k0.59%
A$ 321.9k
Michael Southard
Non Executive Director6.1yrsAU$59.19k0.0087%
A$ 4.8k
Daniel Webb
Independent Director1.8yrsAU$36.65k0.24%
A$ 133.3k

6.1yrs

Durée moyenne de l'emploi

62yo

Âge moyen

Conseil d'administration expérimenté: EYE's board of directors are considered experienced (6.1 years average tenure).